3rd Quarter - Report — FABIANI & COMPANY for EDISON PHARMACEUTICALS (2011)

Firm

FABIANI & COMPANY

Client

EDISON PHARMACEUTICALS

Income

—

Expenses

—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Defense Appropriations Act, developmental funding for therapeutics for hereditary and acquired mitochondrial diseases.

Lobbyist	Covered position, as disclosed
ELIZABETH BARROWS	—

Contacted: Defense Advanced Research Projects Agency (DARPA); Defense, Dept of (DOD)

Defense DEF

Defense Appropriations Act, developmental funding for therapeutics for hereditary and acquired mitochondrial diseases.

Lobbyist	Covered position, as disclosed
ELIZABETH BARROWS	—

Contacted: Defense, Dept of (DOD); Defense Advanced Research Projects Agency (DARPA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.